A Structurally Stabilized Lipopolymer Nanoplatform Targeting Pan‐Tissue Antigen‐Presenting Cells Enables Durable in situ mRNA Cancer Immunotherapy
L L Zeng(Sun Yat-sen University), Xuesi Chen(State Key Laboratory of Polymer Physics and Chemistry), Lingyu Wei(East China University of Science and Technology), Zixi Zhang(First Affiliated Hospital of Xi'an Jiaotong University), Jinjin Chen(Sichuan University), M J Jiang(Sun Yat-sen University), Yupeng Ren(Southwest Minzu University), Qian Shen(Sun Yat-sen University), Hui Fan(University of South China), Jing Liao(Sun Yat-sen University), Jianxun Ding(State Key Laboratory of Polymer Physics and Chemistry), Xinxiu Cao
Cited by 0
Related Papers
Lung-selective mRNA delivery of synthetic lipid nanoparticles for the treatment of pulmonary lymphangioleiomyomatosis
|Proceedings of the National Academy of Sciences|2022|495
Lipid nanoparticle-mediated lymph node–targeting delivery of mRNA cancer vaccine elicits robust CD8 <sup>+</sup> T cell response
|Proceedings of the National Academy of Sciences|2022|411
Lipid nanoparticle-mediated codelivery of Cas9 mRNA and single-guide RNA achieves liver-specific in vivo genome editing of <i>Angptl3</i>
|Proceedings of the National Academy of Sciences|2021|390
Imidazole‐Based Synthetic Lipidoids for In Vivo mRNA Delivery into Primary T Lymphocytes
|Angewandte Chemie International Edition|2020|176
Epstein-Barr Virus miR-BART6-3p Inhibits the RIG-I Pathway
|Journal of Innate Immunity|2017|122